Phase I Trials of Molecularly Targeted Agents: Should We Pay More Attention to Late Toxicities?

The key of understanding for molecularly imprinted polymer is the research on the selective mechanism.

This review attempts to concisely summarize the molecularly targeted therapy of advanced hepatocellular carcinoma.